Načítá se...
Combination Therapy: Histone Deacetylase Inhibitors and Platinum-based Chemotherapeutics for Cancer
One of the most promising strategies to increase the efficacy of standard chemotherapy drugs is by combining them with low doses of histone deacetylases inhibitors (HDACis). Regarded as chemosensitizers, the addition of well-tolerated doses of HDACis to platinum-based chemotherapeutics has been prov...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3546543/ https://ncbi.nlm.nih.gov/pubmed/23032720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2012.09.018 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|